Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

How much do PPIs contribute to C. difficile infections?

Leontiadis GI, Miller MA, Howden CW.

Am J Gastroenterol. 2012 Jul;107(7):1020-1. doi: 10.1038/ajg.2012.174.

PMID:
22764024
2.

Does confounding explain the association between PPIs and Clostridium difficile-related diarrhea?

Freedberg DE, Abrams JA.

Am J Gastroenterol. 2013 Feb;108(2):278-9. doi: 10.1038/ajg.2012.395. No abstract available.

PMID:
23381076
3.

Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.

Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK.

Am J Gastroenterol. 2012 Jul;107(7):1011-9. doi: 10.1038/ajg.2012.108. Epub 2012 Apr 24. Erratum in: Am J Gastroenterol. 2014 Jan;109(1):144.

PMID:
22525304
4.

Proton pump inhibitor use may be associated with an increased risk of Clostridium difficile infection.

Stevens V, van Wijngaarden E.

Evid Based Med. 2013 Oct;18(5):193-4. doi: 10.1136/eb-2012-101057. Epub 2012 Dec 8. No abstract available.

PMID:
23220471
5.

Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation.

Chandra S, Agarwal D, Surana A.

Am J Gastroenterol. 2013 Feb;108(2):277-8. doi: 10.1038/ajg.2012.394. No abstract available.

PMID:
23381074
6.

Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.

Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN.

Am J Gastroenterol. 2012 Jul;107(7):1001-10. doi: 10.1038/ajg.2012.179. Epub 2012 Jun 19.

PMID:
22710578
7.

Response to Chandra et al., and Freedberg and Abrams.

Loke YK, Kwok CS.

Am J Gastroenterol. 2013 Feb;108(2):279-80. doi: 10.1038/ajg.2012.397. No abstract available.

PMID:
23381077
8.

Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.

Tariq R, Singh S, Gupta A, Pardi DS, Khanna S.

JAMA Intern Med. 2017 Jun 1;177(6):784-791. doi: 10.1001/jamainternmed.2017.0212. Review.

PMID:
28346595
9.

Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.

Stevens V, Dumyati G, Brown J, Wijngaarden E.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1035-42. doi: 10.1002/pds.2198. Epub 2011 Aug 10.

PMID:
21833992
10.

Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.

Turco R, Martinelli M, Miele E, Roscetto E, Del Pezzo M, Greco L, Staiano A.

Aliment Pharmacol Ther. 2010 Apr;31(7):754-9. doi: 10.1111/j.1365-2036.2009.04229.x. Epub 2009 Dec 29.

11.

Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.

Hung YP, Ko WC, Chou PH, Chen YH, Lin HJ, Liu YH, Tsai HW, Lee JC, Tsai PJ.

J Infect Dis. 2015 Aug 15;212(4):654-63. doi: 10.1093/infdis/jiv184. Epub 2015 Mar 24.

PMID:
25805751
12.

Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.

MacLaren R, Kassel LE, Kiser TH, Fish DN.

Expert Opin Drug Saf. 2015 Feb;14(2):269-80. doi: 10.1517/14740338.2015.986456. Epub 2014 Nov 25. Review.

PMID:
25423448
13.

Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.

Deshpande A, Pant C, Pasupuleti V, Rolston DD, Jain A, Deshpande N, Thota P, Sferra TJ, Hernandez AV.

Clin Gastroenterol Hepatol. 2012 Mar;10(3):225-33. doi: 10.1016/j.cgh.2011.09.030. Epub 2011 Oct 20.

PMID:
22019794
14.

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D.

Arch Intern Med. 2010 May 10;170(9):784-90. doi: 10.1001/archinternmed.2010.89.

PMID:
20458086
15.

Does PPI therapy predispose to Clostridium difficile infection?

Pant C, Madonia P, Minocha A.

Nat Rev Gastroenterol Hepatol. 2009 Sep;6(9):555-7. doi: 10.1038/nrgastro.2009.128. Review.

PMID:
19713988
16.
17.

Proton pump inhibitors: Clostridium difficile infections.

[No authors listed]

Prescrire Int. 2013 Oct;22(142):239-40.

PMID:
24298587
18.

Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy.

Mizui T, Teramachi H, Tachi T, Tamura K, Shiga H, Komada N, Umeda M, Koda A, Aoyama S, Goto C, Tsuchiya T.

Pharmazie. 2013 Aug;68(8):706-10.

PMID:
24020129
19.

Proton pump inhibitors and risk for recurrent Clostridium difficile infection.

Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA.

Arch Intern Med. 2010 May 10;170(9):772-8. doi: 10.1001/archinternmed.2010.73. Erratum in: Arch Intern Med. 2010 Jul 12;170(13):1100.

PMID:
20458084
20.

Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.

Tleyjeh IM, Bin Abdulhak AA, Riaz M, Alasmari FA, Garbati MA, AlGhamdi M, Khan AR, Al Tannir M, Erwin PJ, Ibrahim T, Allehibi A, Baddour LM, Sutton AJ.

PLoS One. 2012;7(12):e50836. doi: 10.1371/journal.pone.0050836. Epub 2012 Dec 7. Review.

Supplemental Content

Support Center